BCR and neoplasm: Different properties of BCR signaling have been identified in normal B cells and in lymphoma B cells from follicular lymphoma patients[20,21], and impaired BCR signaling identified a subset of follicular lymphoma tumor cells with negative prognostic impact on patients overall survival[22].